Meeting
2024 ASCO Genitourinary Cancers Symposium
Long-term treatment outcomes from the International Multi-Institutional Stereotactic Body Radiation Therapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium.
Authors
Luca Faustino Valle
Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA
Luca Faustino Valle , Tahmineh Romero , Tommy Jiang , Ritchell Van Dams , Donald B. Fuller , Andrew Loblaw , Thomas Kennedy , Sean P. Collins , Vaibhav Sharma , Simeng Suy , Vedang Murthy , Indranil Mallick , Nicholas George Nickols , Michael L. Steinberg , Amar Upadhyaya Kishan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Therapeutics
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 323)
DOI
10.1200/JCO.2024.42.4_suppl.323
Abstract #
323
Poster Bd #
N14
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Multi-institutional analysis of high-risk prostate cancer patients treated with stereotactic body radiotherapy.
First Author: Naomi Y Jiang
Poster
2020 Genitourinary Cancers Symposium
Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): Efficacy, survival, and late toxicity outcomes.
First Author: Andrew Loblaw
Poster
2018 Genitourinary Cancers Symposium
Long-term outcomes of stereotactic body radiotherapy for low- and intermediate-risk prostate adenocarcinoma: A multi-institutional consortium study.
First Author: Amar Upadhyaya Kishan
Poster
2017 Genitourinary Cancers Symposium
Management of high-risk prostate cancer with 5-treatment stereotactic body radiotherapy: Long-term results.
First Author: Josephine Kang